Whitepaper: The value and benefits of rapid mold detection in the pharmaceutical industry
Supported by:
Published: 28 November 2023
Share this post
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
Address the importance of accurate microbial identifications and proper contamination control for effective mold remediation.
Mold contamination poses a significant risk to pharmaceutical manufacturing facilities as it can compromise the integrity of products and potentially harm patients. This whitepaper highlights the value and benefits of rapid mold detection within a day, emphasises the importance of accurate microbial identifications and the significance of performing quality control disinfection protocols.
Authors Danielle Decesaro, Rapid Micro Biosystems, and Ziva Abraham, Microrite, Inc, share the importance of the timely response and mitigation of early mold detection, as well as the cost savings for pharmaceutical companies. They’ll also discuss regulatory compliance, targeted remediation strategies and contamination prevention.
Download this whitepaper by registering your details in the box to read the full article.
